Enzyme immunoassay for the quantitative determination of free Aflibercept (Eylea®, Zaltrap®) in serum and plasma.
The solid phase (MTP) is coated by the target molecule, in this case VEGF.
Legal Status: CE-Mark
Intended Use: This kit has been developed for the measurement of drug levels in research, diagnostic and biosimilar uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Quality Control Certificates
Eylea® is a trademark of Bayer.
Zaltrap® is a trademark of Sanofi Genzyme.
The Kit at a glance:
|Required Volume (µL)||10|
|Incubation Time (min)||105|
|Sample||Serum or Plasma|
|Package Size||96 Tests|
|Standard Range (ng/mL, 10x)||0-2000|
|Detection Limit (ng/mL)||5|
|Spike Recovery (%)||>95|
|Shelf Life (years)||2|